India's clean energy push faces a major test as transmission bottlenecks in Rajasthan highlight curtailment risks, grid ...

Learn how root cause analysis and integrated data prevent hydropower bearing failures, reduce costly downtime, and improve ...

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

It doesn't make a huge difference in performance or fuel economy, but it'll net you more thumbs-ups in the Whole Foods ...